John Cosby - Oasmia Pharmaceutical Head Affairs
Insider
John Cosby is Head Affairs of Oasmia Pharmaceutical AB
| Age | 61 |
| Phone | 46 18 50 54 40 |
| Web | https://www.vivesto.com |
Oasmia Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of (0.0875) % which means that it has lost $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2542) %, meaning that it generated substantial loss on money invested by shareholders. Oasmia Pharmaceutical's management efficiency ratios could be used to measure how well Oasmia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mischa Reis | Envista Holdings Corp | 53 | |
| Nicholas Smith | AG Mortgage Investment | 44 | |
| Vivek Jain | Envista Holdings Corp | 60 | |
| Kieran Gallahue | Envista Holdings Corp | 57 | |
| Gordon Wadley | Dream Office Real | N/A | |
| Tianliang Zhang | Shenzhen Investment Holdings | 59 | |
| Dianne Hurley | AG Mortgage Investment | 58 | |
| Gregory Pelton | Iridium Communications | N/A | |
| Gayle Sheppard | Envista Holdings Corp | 66 | |
| Christine Tsingos | Envista Holdings Corp | 62 | |
| Ji Liu | Shenzhen Investment Holdings | 48 | |
| John Hargraves | Precision Optics, | N/A | |
| Juan Arbona | Envista Holdings Corp | N/A | |
| ACIS ACS | Shenzhen Investment Holdings | 52 | |
| Daniel Raskas | Envista Holdings Corp | 54 | |
| Kwok Leung | Shenzhen Investment Holdings | 60 | |
| Suzanne McBride | Iridium Communications | 55 | |
| Richard Forkey | Precision Optics, | 85 | |
| Christopher Moore | AG Mortgage Investment | N/A | |
| Eric Conley | Envista Holdings Corp | N/A | |
| Jay CA | Dream Office Real | N/A | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 |
Oasmia Pharmaceutical Leadership Team
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson, Chief Officer | ||
| Urban Ekelund, IR Mang | ||
| Henrik Rnnberg, Chief Health | ||
| John Cosby, Head Affairs | ||
| Robert Maiorana, Head CFO | ||
| Dzianis Babrou, Head Devel | ||
| Christer MD, Acting Officer | ||
| Reinhard Koenig, Chief Officer | ||
| Johanna Rostin, Head Affairs | ||
| Maria Hagberg, Head Affairs |
Oasmia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oasmia Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |